Am J Heart 229:6169 Kadawaki T, Isendahl JK, Khalid U, Lee SW et al (2022) Semaglutide once a week in adults with overweight or obesity, with or without type 2 diabetes in an east Asian population (STEP 6): a randomised, double-blind, double-dummy, placebo-controlled, phase 3a trial
Ametov A, Kamynina L, Akhmedova Z
Working with a knowledgeable healthcare professional, like a Midi clinician, can help you find a safe, appropriate planeven while new medications are still in development
Secure checkout with multiple payment options
Cons No medical oversight : Empower offers prescriptions only no coaching, no treatment planning, and no check-ins